TIAA CREF Investment Management’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $467K | Sell |
77,958
-45,983
| -37% | -$275K | ﹤0.01% | 2625 |
|
|
2018
Q4 | $916K | Sell |
123,941
-58,578
| -32% | -$433K | ﹤0.01% | 2318 |
|
|
2018
Q3 | $2.65M | Sell |
182,519
-22,512
| -11% | -$327K | ﹤0.01% | 1971 |
|
|
2018
Q2 | $4.09M | Buy |
205,031
+2,213
| +1% | +$44.2K | ﹤0.01% | 1746 |
|
|
2018
Q1 | $3.55M | Hold |
202,818
| – | – | ﹤0.01% | 1780 |
|
|
2017
Q4 | $5M | Sell |
202,818
-27,330
| -12% | -$674K | ﹤0.01% | 1594 |
|
|
2017
Q3 | $5.94M | Buy |
230,148
+15,207
| +7% | +$392K | ﹤0.01% | 1513 |
|
|
2017
Q2 | $5.83M | Buy |
214,941
+36,667
| +21% | +$994K | ﹤0.01% | 1498 |
|
|
2017
Q1 | $5.32M | Sell |
178,274
-1,108
| -0.6% | -$33K | ﹤0.01% | 1559 |
|
|
2016
Q4 | $4.87M | Buy |
179,382
+150,942
| +531% | +$4.1M | ﹤0.01% | 1626 |
|
|
2016
Q3 | $728 | Hold |
28,440
| – | – | ﹤0.01% | 2703 |
|
|
2016
Q2 | $525K | Buy |
28,440
+15,487
| +120% | +$286K | ﹤0.01% | 2833 |
|
|
2016
Q1 | $245K | Hold |
12,953
| – | – | ﹤0.01% | 2952 |
|
|
2015
Q4 | $349K | Buy |
+12,953
| New | +$349K | ﹤0.01% | 2989 |
|